Sandra Santasusagna

682 total citations
13 papers, 511 citations indexed

About

Sandra Santasusagna is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sandra Santasusagna has authored 13 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sandra Santasusagna's work include MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (6 papers). Sandra Santasusagna is often cited by papers focused on MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (6 papers). Sandra Santasusagna collaborates with scholars based in Spain and United States. Sandra Santasusagna's co-authors include Alfons Navarro, Mariano Monzó, Carmen Muñoz, Núria Viñolas, José Ramírez, Ramón M. Marrades, Laureano Molins, Marc Ruíz-Martínez, Joan J. Castellano and Raquel Hernández and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Urology.

In The Last Decade

Sandra Santasusagna

13 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Santasusagna Spain 12 431 392 64 52 26 13 511
Haijiao Yan China 11 343 0.8× 302 0.8× 128 2.0× 35 0.7× 33 1.3× 23 466
Xun Zhu China 10 492 1.1× 421 1.1× 79 1.2× 45 0.9× 27 1.0× 16 610
Yugang Ge China 11 256 0.6× 207 0.5× 53 0.8× 44 0.8× 34 1.3× 17 330
Matthew F. Jones United States 10 304 0.7× 283 0.7× 104 1.6× 22 0.4× 18 0.7× 13 463
Juanyi Shi China 13 503 1.2× 444 1.1× 68 1.1× 111 2.1× 56 2.2× 29 626
Zehui Hou China 11 265 0.6× 223 0.6× 55 0.9× 34 0.7× 22 0.8× 20 341
Adelheid End‐Pfützenreuter Austria 6 323 0.7× 195 0.5× 38 0.6× 36 0.7× 20 0.8× 9 389
Jiangnan Qiu China 9 286 0.7× 218 0.6× 36 0.6× 46 0.9× 19 0.7× 13 359
Xuehu Xu China 12 291 0.7× 218 0.6× 42 0.7× 33 0.6× 16 0.6× 17 356
Huangyang Meng China 12 306 0.7× 236 0.6× 85 1.3× 129 2.5× 20 0.8× 22 423

Countries citing papers authored by Sandra Santasusagna

Since Specialization
Citations

This map shows the geographic impact of Sandra Santasusagna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Santasusagna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Santasusagna more than expected).

Fields of papers citing papers by Sandra Santasusagna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Santasusagna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Santasusagna. The network helps show where Sandra Santasusagna may publish in the future.

Co-authorship network of co-authors of Sandra Santasusagna

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Santasusagna. A scholar is included among the top collaborators of Sandra Santasusagna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Santasusagna. Sandra Santasusagna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Woo, JungReem, Sandra Santasusagna, Kamlesh K. Yadav, et al.. (2020). Urine Extracellular Vesicle GATA2 mRNA Discriminates Biopsy Result in Men with Suspicion of Prostate Cancer. The Journal of Urology. 204(4). 691–700. 15 indexed citations
2.
Navarro, Alfons, Jorge Moisés, Sandra Santasusagna, et al.. (2019). Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer. BMC Pulmonary Medicine. 19(1). 55–55. 24 indexed citations
3.
Woo, JungReem, Sandra Santasusagna, Benjamin E. Leiby, et al.. (2019). GATA2 exosomal mRNA: A novel urine biomarker for the diagnosis of clinically significant prostate cancer.. Journal of Clinical Oncology. 37(7_suppl). 18–18. 3 indexed citations
4.
Santasusagna, Sandra, Isabel Moreno, Alfons Navarro, et al.. (2018). Proteomic Analysis of Liquid Biopsy from Tumor-Draining Vein Indicates that High Expression of Exosomal ECM1 Is Associated with Relapse in Stage I-III Colon Cancer. Translational Oncology. 11(3). 715–721. 20 indexed citations
5.
Campayo, Marc, Alfons Navarro, José Carlos Benítez, et al.. (2018). miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer. PLoS ONE. 13(11). e0206542–e0206542. 36 indexed citations
6.
Santasusagna, Sandra, Isabel Moreno, Alfons Navarro, et al.. (2018). Prognostic Impact of miR-200 Family Members in Plasma and Exosomes from Tumor-Draining versus Peripheral Veins of Colon Cancer Patients. Oncology. 95(5). 309–318. 39 indexed citations
7.
Santasusagna, Sandra, I. Moreno, Alfons Navarro, et al.. (2018). miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1. Clinical & Translational Oncology. 20(9). 1161–1167. 43 indexed citations
8.
Moisés, Jorge, Alfons Navarro, Sandra Santasusagna, et al.. (2017). NKX2–1 expression as a prognostic marker in early-stage non-small-cell lung cancer. BMC Pulmonary Medicine. 17(1). 197–197. 23 indexed citations
9.
Monzó, Mariano, Sandra Santasusagna, Isabel Moreno, et al.. (2017). Exosomal microRNAs isolated from plasma of mesenteric veins linked to liver metastases in resected patients with colon cancer. Oncotarget. 8(19). 30859–30869. 39 indexed citations
10.
Caritg, Oriol, Alfons Navarro, Isabel Moreno, et al.. (2016). Identifying High-Risk Stage II Colon Cancer Patients: A Three-MicroRNA-Based Score as a Prognostic Biomarker. Clinical Colorectal Cancer. 15(4). e175–e182. 38 indexed citations
11.
Ruíz-Martínez, Marc, Alfons Navarro, Ramón M. Marrades, et al.. (2016). YKT6 expression, exosome release, and survival in non-small cell lung cancer. Oncotarget. 7(32). 51515–51524. 104 indexed citations
12.
Monzó, Mariano, F Martínez-Ródenas, Isabel Moreno, et al.. (2015). Differential MIR-21 Expression in Plasma From Mesenteric Versus Peripheral Veins. Medicine. 94(1). e145–e145. 13 indexed citations
13.
Tejero, Rut, Alfons Navarro, Marc Campayo, et al.. (2014). miR-141 and miR-200c as Markers of Overall Survival in Early Stage Non-Small Cell Lung Cancer Adenocarcinoma. PLoS ONE. 9(7). e101899–e101899. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026